Literature DB >> 16085492

Homologous recombination rescues mismatch-repair-dependent cytotoxicity of S(N)1-type methylating agents in S. cerevisiae.

Petr Cejka1, Nina Mojas, Ludovic Gillet, Primo Schär, Josef Jiricny.   

Abstract

Resistance of mammalian cells to S(N)1-type methylating agents such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) generally arises through increased expression of methylguanine methyltransferase (MGMT), which reverts the cytotoxic O(6)-methylguanine ((Me)G) to guanine, or through inactivation of the mismatch repair (MMR) system, which triggers cell death through aberrant processing of (Me)G/T mispairs generated during DNA replication when MGMT capacity is exceeded. Given that MMR and (Me)G-detoxifying proteins are functionally conserved through evolution, and that MMR-deficient Escherichia coli dam(-) strains are also resistant to MNNG, the finding that MMR status did not affect the sensitivity of Saccharomyces cerevisiae to MNNG was unexpected. Because (Me)G residues in DNA trigger homologous recombination (HR), we wondered whether the efficient HR in S. cerevisiae might alleviate the cytotoxic effects of (Me)G processing. We now show that HR inactivation sensitizes S. cerevisiae to MNNG and that, as in human cells, defects in the MMR genes MLH1 and MSH2 rescue this sensitivity. Inactivation of the EXO1 gene, which encodes the only exonuclease implicated in MMR to date, failed to rescue the hypersensitivity, which implies that scExo1 is not involved in the processing of (Me)G residues by the S. cerevisiae MMR system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085492     DOI: 10.1016/j.cub.2005.07.032

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  22 in total

1.  ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.

Authors:  Ken-ichi Yoshioka; Yoshiko Yoshioka; Peggy Hsieh
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

Review 2.  Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks.

Authors:  Michael D Wyatt; Douglas L Pittman
Journal:  Chem Res Toxicol       Date:  2006-12       Impact factor: 3.739

3.  Involvement of deoxycytidylate deaminase in the response to S(n)1-type methylation DNA damage in budding yeast.

Authors:  R Michael Liskay; Linda J Wheeler; Christopher K Mathews; Naz Erdeniz
Journal:  Curr Biol       Date:  2007-09-04       Impact factor: 10.834

Review 4.  DNA repair mechanisms and the bypass of DNA damage in Saccharomyces cerevisiae.

Authors:  Serge Boiteux; Sue Jinks-Robertson
Journal:  Genetics       Date:  2013-04       Impact factor: 4.562

5.  The Major Replicative Histone Chaperone CAF-1 Suppresses the Activity of the DNA Mismatch Repair System in the Cytotoxic Response to a DNA-methylating Agent.

Authors:  Lyudmila Y Kadyrova; Basanta K Dahal; Farid A Kadyrov
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

6.  Nuclear reorganization of DNA mismatch repair proteins in response to DNA damage.

Authors:  Adam S Mastrocola; Christopher D Heinen
Journal:  DNA Repair (Amst)       Date:  2009-12-08

7.  DNA mismatch repair-induced double-strand breaks.

Authors:  Anetta Nowosielska; M G Marinus
Journal:  DNA Repair (Amst)       Date:  2007-09-10

8.  Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.

Authors:  Eugene Izumchenko; John Saydi; Kevin D Brown
Journal:  DNA Repair (Amst)       Date:  2012-10-11

9.  Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA.

Authors:  Nina Mojas; Massimo Lopes; Josef Jiricny
Journal:  Genes Dev       Date:  2007-12-15       Impact factor: 11.361

10.  Interplay of DNA repair pathways controls methylation damage toxicity in Saccharomyces cerevisiae.

Authors:  Petr Cejka; Josef Jiricny
Journal:  Genetics       Date:  2008-06-24       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.